Formulation and Delivery
Srinivasan Shanmugam, PhD
Executive Director, Pharmaceutical Sciences
Adare Pharma Solutions
Vandalia, Ohio
Description: Dysphagia, which predominately affects pediatric and geriatric patients, necessitates patient-centric, easy-to-swallow dosage forms to improve compliance and outcomes. This presentation explores novel formulations like orally disintegrating tablets, mini-tablets, gels, and liquids, focusing on enhancing swallowability through taste masking, texture modification, and ease of administration. Our study assesses these formulations for safety, efficacy, and patient acceptability, underscoring the critical role of patient-centric design in advancing dysphagia therapies and future dosage innovations for special populations.